Pharma & Healthcare Insight brings you analysis of regional trends, regulatory changes, projects and investments plus competitive intelligence on the growth strategies of leading companies in the sector

See Prices or Subscribe

Key stories from this month's issue...

Industry Trend Analysis - Generics Continue To Generate Market Growth - JAN 2015

Americas November 2014 / Brazil / Industry

An ageing population, multinational investment, and enormous market expansion mean that Brazil's generic drug sector will continue to be the regional outperformer for growth in Latin America. The country's high levels of generic drug consumption as well as favourable laws make this market an attractive destination for generic drug investment and manufacturing.


Industry Trend Analysis - Generic Drug Firms To Outperform Innovative Peers - JAN 2015

Asia November 2014 / Japan / Industry

Japanese generic drug manufacturers will outperform their patented drug pharmaceutical peers given the market's potential for growth as well as cost containment measures by the government shifting. The country is the second largest pharmaceutical market globally and even small increases in demand will translate into strong revenue earning opportunities for drug companies.


Industry Trend Analysis - H114 Sales Data Supports Forecast Changes - OCT 2014

Emerging Europe September 2014 / Ukraine / Industry

In line with our view, price inflation is contributing to pharmaceutical volume drop-off in Ukraine. Sales have risen in local currency terms, but declined in real terms. We see the remainder of 2014 and 2015 as being particularly challenging within Ukraine owing to upcoming headwinds and distressed market conditions.


Industry Trend Analysis - Increased Budget Allocation To Provide Opportunities For Drugmakers - JAN 2015

Middle East & Africa November 2014 / United Arab Emirates / Industry

Continued government investment in the healthcare sector, increasing economic growth from the non-oil sector and improved intellectual property legislation mean that the UAE will remain an attractive pharmaceutical market for drugmakers.


Industry Trend Analysis - Health Economics Driving Global Home Care Growth - JAN 2015

Western Europe November 2014 / Global / Industry

Home care will become an increasingly important segment of global healthcare, driven by the increasing engagement of consumers to proactively monitor and manage their health, and by pressures on global healthcare systems to deliver more efficient and affordable care. Both developed and emerging markets will increasingly adopt a home care model, as a result of different, yet equally relevant economic factors.